Novel analytical methodologies, real-world data (RWD), innovative trial designs, and new technologies are crucial to optimise ...

The Interministerial Commission for the Pricing of Medicines in Spain has backed access by the Spanish National Health System ...

Unique, patient-focused manufacturing models are needed to scale up innovative cell therapies for cancer and one company, ...

There is huge unmet need for new rare disease therapies, where patients have few or no available options. According to the ...

JAK inhibitor Rinvoq (upadacitinib) has been backed by the CHMP as a 15mg, once-daily treatment for adults with GCA, an ...

"Many loss of pulse incidents happen when the person is alone, leaving them with effectively no chance of receiving ...

Other companies use customer reference and patient data to improve operational agility as they launch and scale their first ...

Artificial intelligence specialist Owkin has added another piece to its medical research portfolio with the launch of ...

US District Judge William Alsup's restraining order has been granted on the grounds that the Office of Personnel Management ...

I envision Chiesi as a proactive leader driving innovation and collaboration within the rare disease community. Our goal is ...

As the demands of modern healthcare grow, new therapies are introduced at record speeds, and guidelines are quickly updated, it is key that medical education evolves to keep up. Traditional ...

Pursue advocacy efforts We’ve seen critical legal decisions over the last five years either accelerate or stymie the United States biosimilar market. In the 2017 Amgen v. Sandoz case, the ...